Afsha Aurshina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Afsha Aurshina has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
Enrico Ascher
Vascular Institute of New York, Brooklyn, NY
31 shared publications- Anil Hingorani
Division of Vascular Surgery, NYU Langone Hospital-Brooklyn, Brooklyn, NY
27 shared publications Natalie Marks
Vascular Institute of New York, Brooklyn, NY
26 shared publications- Ahmad Alsheekh
Vascular Institute of New York, Brooklyn, NY, USA
11 shared publications Pavel Kibrik
Vascular Institute of New York, Brooklyn, NY
8 shared publicationsAmrit Hingorani
Vascular Institute of New York, Brooklyn, NY
7 shared publications
Latest Publications
- 1 September 2021
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 74 (3) , 958-962
Physician impact on use of fluoroscopy during endovascular procedures to improve radiation safety
- 1 September 2021
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 74 (3) , 958-962
Physician impact on use of fluoroscopy during endovascular procedures to improve radiation safety
- 1 April 2021
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 73 (4) , 1298-1303
Safety of vascular interventions performed in an office-based laboratory in patients with low/moderate procedural risk
- 1 April 2021
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 73 (4) , 1298-1303
Safety of vascular interventions performed in an office-based laboratory in patients with low/moderate procedural risk
- 1 March 2020
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 8 (2) , 207-210
Etiology of iliocaval stent thrombosis
- 1 March 2020
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 8 (2) , 207-210
Etiology of iliocaval stent thrombosis
- 1 February 2020
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 63, 307-310
Iliac Vein Stent Placement and the Iliocaval Confluence
- 1 February 2020
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 63, 307-310
Iliac Vein Stent Placement and the Iliocaval Confluence
- 1 October 2019
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 60, 178-181
Early Results of Duplex-Guided Transradial Artery Fistuloplasties
- 1 October 2019
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 60, 178-181
Early Results of Duplex-Guided Transradial Artery Fistuloplasties
- 21 July 2019
- Published by SAGE Publications in Vascular and Endovascular Surgery
- Vol. 53 (7) , 558-562
Comparison of Ultrasound-Accelerated Versus Multi-Hole Infusion Catheter-Directed Thrombolysis for the Treatment of Acute Limb Ischemia
Objective: Thrombolytic therapy is widely used in the treatment of arterial occlusions causing acute limb ischemia (ALI); however, knowledge regarding the efficacy of the different catheter systems available is scarce. The objective of this study was to compare the safety and efficacy of 2 catheter-directed infusion systems for intra-arterial thrombolysis in the setting of ALI. Methods: A retrospective analysis was conducted to study all catheter-directed thrombolysis procedures performed over 32 months in patients diagnosed with ALI. Patients with thrombosis in both native arteries and bypass grafts were included. Patients with contraindications to thrombolysis, or those receiving thrombolysis for deep venous thrombosis, were excluded. The duration of thrombolysis, amount of thrombolytic agent, and technical success rate were recorded. Technical success was defined as complete or near-complete resolution of thrombus burden, allowing for further intervention. Data were stratified to include location of thrombus, procedural complications, mortality, and rates of limb loss. Results: Ninety-one patients met inclusion criteria. Among them, Uni-Fuse and EKOS catheters were used in 69 and 22 patients, respectively. The mean age of the population was 71 (standard deviation [SD]: ±1.5) for patients treated with the EKOS catheter and 70 years (SD: ±2.6) for patients receiving thrombolysis with Uni-Fuse. There was no significant difference in the mean infusion duration (1.65 vs 1.9 days), volume of tissue plasminogen activator (44.6 vs 48.2 mg), or technical success rate (72% vs 86%) between the Uni-Fuse and EKOS cohorts ( P > .3). Furthermore, there was no difference in major limb loss or compartment syndrome between each group ( P > .4). The overall complication rate was 14% in both groups, with a 30-day mortality rate of 4% when treated with either catheter system. Conclusion: This study suggests that a standard multi-hole infusion catheter demonstrates similar clinical safety and efficacy as the ultrasound-accelerated EKOS system in the treatment of ALI.
- 21 July 2019
- Published by SAGE Publications in Vascular and Endovascular Surgery
- Vol. 53 (7) , 558-562
Comparison of Ultrasound-Accelerated Versus Multi-Hole Infusion Catheter-Directed Thrombolysis for the Treatment of Acute Limb Ischemia
Objective: Thrombolytic therapy is widely used in the treatment of arterial occlusions causing acute limb ischemia (ALI); however, knowledge regarding the efficacy of the different catheter systems available is scarce. The objective of this study was to compare the safety and efficacy of 2 catheter-directed infusion systems for intra-arterial thrombolysis in the setting of ALI. Methods: A retrospective analysis was conducted to study all catheter-directed thrombolysis procedures performed over 32 months in patients diagnosed with ALI. Patients with thrombosis in both native arteries and bypass grafts were included. Patients with contraindications to thrombolysis, or those receiving thrombolysis for deep venous thrombosis, were excluded. The duration of thrombolysis, amount of thrombolytic agent, and technical success rate were recorded. Technical success was defined as complete or near-complete resolution of thrombus burden, allowing for further intervention. Data were stratified to include location of thrombus, procedural complications, mortality, and rates of limb loss. Results: Ninety-one patients met inclusion criteria. Among them, Uni-Fuse and EKOS catheters were used in 69 and 22 patients, respectively. The mean age of the population was 71 (standard deviation [SD]: ±1.5) for patients treated with the EKOS catheter and 70 years (SD: ±2.6) for patients receiving thrombolysis with Uni-Fuse. There was no significant difference in the mean infusion duration (1.65 vs 1.9 days), volume of tissue plasminogen activator (44.6 vs 48.2 mg), or technical success rate (72% vs 86%) between the Uni-Fuse and EKOS cohorts ( P > .3). Furthermore, there was no difference in major limb loss or compartment syndrome between each group ( P > .4). The overall complication rate was 14% in both groups, with a 30-day mortality rate of 4% when treated with either catheter system. Conclusion: This study suggests that a standard multi-hole infusion catheter demonstrates similar clinical safety and efficacy as the ultrasound-accelerated EKOS system in the treatment of ALI.
- 1 July 2019
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 7 (4) , 543-546
Routine use of ultrasound to avert mechanical complications during placement of tunneled dialysis catheters for hemodialysis
- 1 July 2019
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 7 (4) , 543-546
Routine use of ultrasound to avert mechanical complications during placement of tunneled dialysis catheters for hemodialysis
- 1 July 2019
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 7 (4) , 507-513
Patient perspectives on inferior vena cava filter retrieval
- 1 July 2019
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 7 (4) , 507-513
Patient perspectives on inferior vena cava filter retrieval
- 13 June 2019
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 7 (4) , 522-526
Is it necessary to dilate stents in management of nonthrombotic iliac vein lesions?
- 13 June 2019
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 7 (4) , 522-526
Is it necessary to dilate stents in management of nonthrombotic iliac vein lesions?
- 3 June 2019
- Published by SAGE Publications in Vascular and Endovascular Surgery
- Vol. 53 (6) , 488-491
The Society of Vascular Surgery International Scholars Program: The First Decade
The Society for Vascular Surgery (SVS) is a not-for-profit medical society, whose goal is to further advance in vascular health on a global scale. With its 10th anniversary in sight, we were interested in analyzing the impact of a specific scholarship given under the SVS, the International Scholars Program. Our goal was to examine the awardees’ characteristics and academic productivity. We measured the number of peer-reviewed articles, before and after the program, using PubMed® and Google Scholar® (2008-2018) of the scholarship recipients. Editorials, book chapters, letter to editor, and oral/poster presentations were excluded. A survey was sent out to assess the awardees’ current status. The average number of applicants/year was 15.4 (standard deviation ± 6.69), with 17.5% females and a mean age of 37 ± 3.37 years, with 5.6 ± 2.30 years status post vascular fellowship. Brazil had the highest number of recipients (n = 5; 18.5%) followed by China (n = 4; 14.8%). No significant difference was noted between each country in terms of publications (P = .45), nor with after the SVS scholarship program compared to before (P = .14, 1.84 vs 2.76). The survey concluded 33% had attended a subsequent SVS meeting after the program, with 27% having presented their research (n = 15). The recipients noted the program helped adopt new practices in clinical management (n = 13, 87%), learn new procedures (n = 10, 67%), gain local/regional leadership (n = 9, 60%), and improve technical skills (n = 8, 53%). The most visited clinical sites were Massachusetts General Hospital and Mayo Clinic (n = 4, 27%). The program was given a 9.1/10 rating. The program was successful in maintaining academic productivity by continuing to publish research even after the scholarship, while teaching recipients skills to further improve their career goals. The award remains a competitive process that selects highly skilled recipients and still has much growth and progress to look forward to over the next decade.
- 3 June 2019
- Published by SAGE Publications in Vascular and Endovascular Surgery
- Vol. 53 (6) , 488-491
The Society of Vascular Surgery International Scholars Program: The First Decade
The Society for Vascular Surgery (SVS) is a not-for-profit medical society, whose goal is to further advance in vascular health on a global scale. With its 10th anniversary in sight, we were interested in analyzing the impact of a specific scholarship given under the SVS, the International Scholars Program. Our goal was to examine the awardees’ characteristics and academic productivity. We measured the number of peer-reviewed articles, before and after the program, using PubMed® and Google Scholar® (2008-2018) of the scholarship recipients. Editorials, book chapters, letter to editor, and oral/poster presentations were excluded. A survey was sent out to assess the awardees’ current status. The average number of applicants/year was 15.4 (standard deviation ± 6.69), with 17.5% females and a mean age of 37 ± 3.37 years, with 5.6 ± 2.30 years status post vascular fellowship. Brazil had the highest number of recipients (n = 5; 18.5%) followed by China (n = 4; 14.8%). No significant difference was noted between each country in terms of publications (P = .45), nor with after the SVS scholarship program compared to before (P = .14, 1.84 vs 2.76). The survey concluded 33% had attended a subsequent SVS meeting after the program, with 27% having presented their research (n = 15). The recipients noted the program helped adopt new practices in clinical management (n = 13, 87%), learn new procedures (n = 10, 67%), gain local/regional leadership (n = 9, 60%), and improve technical skills (n = 8, 53%). The most visited clinical sites were Massachusetts General Hospital and Mayo Clinic (n = 4, 27%). The program was given a 9.1/10 rating. The program was successful in maintaining academic productivity by continuing to publish research even after the scholarship, while teaching recipients skills to further improve their career goals. The award remains a competitive process that selects highly skilled recipients and still has much growth and progress to look forward to over the next decade.